Name | Symbol | Markt | Aktientyp |
---|---|---|---|
KemPharm Inc | KMPH | NASDAQ | Common Stock |
Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
---|---|---|---|---|
5,81 | 5,81 |
Aktuelle News
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
29.4.2024 | 13:49 | EDGAR2 | Form DEFA14A - Additional definitive proxy soliciting.. |
10.4.2024 | 22:23 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
10.4.2024 | 13:46 | EDGAR2 | Form 8-K - Current report |
09.4.2024 | 06:15 | EDGAR2 | Form EFFECT - Notice of Effectiveness |
03.4.2024 | 22:17 | EDGAR2 | Form DEFA14A - Additional definitive proxy soliciting.. |
03.4.2024 | 22:15 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
01.4.2024 | 23:27 | EDGAR2 | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
30.6.2023 | 22:14 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |